✦ LIBER ✦

936 TOOKAD ® SOLUBLE (PADELIPORFIN) SECOND GENERATION VASCULAR TARGETED PHOTODYNAMIC THERAPY (VTP) FOR PROSTATE CANCER: SAFETY AND FEASIBILITY

✍ Scribed by N. Arumainayagam; C. Allen; C.M. Moore; N. Barber; R. Hindley; G. Muir; J. Trachtenberg; L. Cormier; E. Barret; A.R. Azzouzi; A. Villers; M. Emberton

Book ID: 119621653
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 166 KB
Volume: 9
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(10)60916-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1788 RESULTS OF TOOKAD® SOLUBLE VASCULAR

1788 RESULTS OF TOOKAD® SOLUBLE VASCULAR TARGETED PHOTODYNAMIC THERAPY (VTP) FOR LOW RISK LOCALIZED PROSTATE CANCER (PCM203)

✍ Azzouzi, Abdel-Rahmene; Barret, Eric; Villers, Arnaud; Muir, Gordon; Moore, Caro 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 54 KB

86 RESULTS OF TOOKAD® SOLUBLE VASCULAR T

86 RESULTS OF TOOKAD® SOLUBLE VASCULAR TARGETED PHOTODYNAMIC THERAPY (VTP) FOR LOW RISK LOCALIZED PROSTATE CANCER (PCM201/PCM203)

✍ A.R. Azzouzi; E. Barret; A. Villers; G. Muir; C.M. Moore; C. Allen; M. Emberton 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 185 KB

TOOKAD ® Soluble vascular-targeted photo

TOOKAD ® Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer

✍ Azzouzi, Abdel-Rahmène; Barret, Eric; Moore, Caroline M.; Villers, Arnaud; Allen 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB

Re: TOOKAD® Soluble Vascular-Targeted Ph

Re: TOOKAD® Soluble Vascular-Targeted Photodynamic (VTP) Therapy: Determination of Optimal Treatment Conditions and Assessment of Effects in Patients with Localised Prostate Cancer

✍ Taneja, Samir S. 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 58 KB

Re: TOOKAD® Soluble Vascular-Targeted Ph

Re: TOOKAD® Soluble Vascular-Targeted Photodynamic (VTP) Therapy: Determination of Optimal Treatment Conditions and Assessment of Effects in Patients with Localised Prostate Cancer

✍ Cadeddu, Jeffrey A. 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 42 KB

Light density index (LDI) is a predictor

Light density index (LDI) is a predictor of MRI and biopsy outcome for WST-11 (Tookad Soluble™) mediated Vascular Targeted Photodynamic therapy (VTP) in focal treatment of localised prostate cancer

✍ S.H. Quoraishi; C.M. Moore; C. Allen; L. Abenhaim; M. Emberton 📂 Article 📅 2010 🏛 SAGE Publications 🌐 English ⚖ 41 KB